Company Filing History:
2 out of 12 
1 out of 3 
1 out of 7 Years Active: 2021-2025
Title: Michal Dadlez: Innovator in Chronic Kidney Disease Diagnosis and Treatment
Introduction
Michal Dadlez is a prominent inventor based in Warsaw, Poland. He has made significant contributions to the field of medical diagnostics, particularly in the area of chronic kidney disease (CKD) and glomerulopathy. With a total of 2 patents, his work focuses on innovative methods for diagnosing and monitoring these conditions.
Latest Patents
Dadlez's latest patents include a method for screening for chronic kidney disease or glomerulopathy, a method for monitoring treatment responses, and a method for treating these conditions. The screening method involves determining the levels of specific protein markers in urine samples, which helps assess the probability of a subject having or being at risk for CKD or glomerulopathy. The monitoring method compares marker levels before and after treatment to evaluate the effectiveness of the intervention. Additionally, his treatment method incorporates the assessment of protein markers to guide therapeutic decisions.
Career Highlights
Throughout his career, Michal Dadlez has worked with notable institutions such as the Medical University of Warsaw and the Institute of Biochemistry and Biophysics of the Polish Academy of Sciences. His research has been instrumental in advancing the understanding and management of kidney diseases.
Collaborations
Dadlez has collaborated with esteemed colleagues, including Krzysztof Mucha and Leszek Paczek, to further enhance the impact of his research in the medical field.
Conclusion
Michal Dadlez's innovative approaches to diagnosing and treating chronic kidney disease and glomerulopathy highlight his significant contributions to medical science. His work continues to pave the way for improved patient outcomes in kidney health.